Instituto Catalan de Oncologia Hospital Duran i Reynals

L'Hospitalet de Llobregat, Catalonia 08908

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Small Cell Lung Cancer

Studies at this site

• A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) — Running, not enrolling